Texas is suing 23andMe to prevent the genetic testing firm from selling personal data of state residents as the company's ...

U.S. Rep. Alexandria Ocasio-Cortez (D-NY), whose district includes parts of the Bronx and Queens, is leading a congressional ...

Three years after litigation started over technology used in Comirnaty, the mRNA vaccine for COVID-19, Biontech SE is acquiring its adversary, Curevac NV, through an all-stock transaction valued at ...

The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate ...

Me’s interim chief executive Joseph Selsavage told lawmakers on Tuesday that 1.9 million people, or about 15% of its customer ...

Defense Secretary Pete Hegseth was quickly met with sharp questions and criticism Tuesday by lawmakers who pressed him about his early moves to deploy troops to Los ...

NEW YORK (Reuters) -Bankrupt genetic testing company 23andMe told a U.S. bankruptcy judge on Wednesday that it wants to ...

In trying to lead before the system could follow, 23andMe outpaced the very guardrails that might have legitimized it”: A ...

A biotech future built on data: Regeneron’s acquisition of 23andMe blurs the line between pharmaceutical innovation and genetic surveillance. Unsplash+ “We are pleased to have reached a ...

Regeneron Pharmaceuticals has promised to comply with 23andMe's existing privacy polices while also using data to fuel drug discovery.

That material, and the genetic data it produced, was 23andMe’s most valuable asset. The company has said any buyer must comply with current privacy protections and federal regulations.

Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 ... subsequent bankruptcy filing has drawn scrutiny from lawmakers who warned that millions ...